Zhejiang NHU (002001) Stock Price, Fundamentals & Analysis

What 002001 does

Zhejiang NHU (002001) is a stock listed on the Shenzhen Stock Exchange in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry. The company, headquartered in Xinchang, China, produces and sells nutritional products, fragrances and flavors, polymer materials, and active pharmaceutical ingredients in China and internationally. It operates through two segments: Pharmaceutical and Chemical; and Other. Its product portfolio includes animal nutrition products such as vitamins, amino acids, and carotenoids for poultry, swine, ruminants, and farmed fish; human nutrition products like vitamins A, D3, E, H, C, B5, B6, and B12, as well as coenzyme Q10, beta carotene, taurine, and l-serine for use in nutritional supplements, food and beverages, and personal care applications; and flavor and fragrance products, including fruity, floral, and green/herbal products for use in soap, toothpaste, shampoo, skin care products, and food and beverage products.

Key numbers explained

• The current price is 25.7 CNY, down 2.43% today. The 52-week range is 22.95 – 40.19, and the price change over the last 52 weeks is 8.2%.
• The trailing P/E ratio of 11 compares the current share price to the last 12 months of earnings per share (2.34 CNY). A lower P/E can suggest the stock is priced more conservatively relative to recent earnings.
• The forward P/E ratio of 9.3 uses expected future earnings, which can indicate how the market views the company's growth outlook.
• The dividend yield is 3.89%, meaning the annual dividend represents 3.89% of the current share price. The ex-dividend date is May 28, 2026, and 43% of earnings are paid out as dividends.
• The beta of 0.25 suggests the stock has historically been less volatile than the overall market.
• The debt-to-equity ratio of 21.1% indicates a relatively low level of debt compared to shareholder equity.
• The return on equity of 22% shows how efficiently the company generates profit from shareholders' equity.
• The price-to-book ratio of 2.26 compares the market price to the company's book value per share.

What to watch

As a Healthcare stock in the Drug Manufacturers - Specialty & Generic industry, Zhejiang NHU (002001) can be influenced by factors such as changes in drug pricing regulations, research and development outcomes, and global demand for nutritional and pharmaceutical ingredients. Investors often monitor revenue growth, which has been 20.7% year over year, and profit margins, with a profit margin of 29.5% and an operating margin of 36.4%. The company's market capitalization of 78.99 mld. CNY places it among larger-cap stocks, and it is part of the CSI 300 index. For those interested in peer companies, Asymchem Laboratories (Tianjin) (002821) and Hualan Biological Engineering (002007) operate in related segments of the Shenzhen Stock Exchange. Broader sector trends and currency fluctuations can also affect performance.